Kadyrov F, Koenig A, Amrute J, Dun H, Li W, Weinheimer C
Nat Cardiovasc Res. 2024; 3(11):1337-1355.
PMID: 39433910
DOI: 10.1038/s44161-024-00553-6.
Aiyengar A, Romano M, Burch M, Lombardi G, Fanelli G
Front Immunol. 2024; 15:1444924.
PMID: 39315099
PMC: 11416935.
DOI: 10.3389/fimmu.2024.1444924.
Jacobs M, Maas R, Jonkman I, Negishi Y, Tielemans Zamora W, Yanginlar C
Cell Rep. 2024; 43(9):114664.
PMID: 39178113
PMC: 11536040.
DOI: 10.1016/j.celrep.2024.114664.
Abdi R
Front Transplant. 2024; 2:1191149.
PMID: 38993889
PMC: 11235337.
DOI: 10.3389/frtra.2023.1191149.
Yokose T, Szuter E, Rosales I, Guinn M, Liss A, Baba T
J Clin Invest. 2024; 134(16).
PMID: 38888968
PMC: 11324304.
DOI: 10.1172/JCI179709.
Biomarkers from subcutaneous engineered tissues predict acute rejection of organ allografts.
Urie R, Morris A, Farris D, Hughes E, Xiao C, Chen J
Sci Adv. 2024; 10(20):eadk6178.
PMID: 38748794
PMC: 11095459.
DOI: 10.1126/sciadv.adk6178.
p40 homodimers bridge ischemic tissue inflammation and heterologous alloimmunity in mice via IL-15 transpresentation.
Tsuda H, Keslar K, Baldwin 3rd W, Heeger P, Valujskikh A, Fairchild R
J Clin Invest. 2024; 134(6).
PMID: 38271093
PMC: 10940089.
DOI: 10.1172/JCI172760.
Heterogeneity in allospecific T cell function in transplant-tolerant hosts determines susceptibility to rejection following infection.
McIntosh C, Allocco J, Wang P, McKeague M, Cassano A, Wang Y
J Clin Invest. 2023; 133(21).
PMID: 37676735
PMC: 10617766.
DOI: 10.1172/JCI168465.
Methods to Study TLRs in Transplantation.
Kwan M, Sepulveda M, Alegre M
Methods Mol Biol. 2023; 2700:139-149.
PMID: 37603178
DOI: 10.1007/978-1-0716-3366-3_7.
Animal Models for Heart Transplantation Focusing on the Pathological Conditions.
Tseng H, Lin Y, Huang C, Shih C, Tsai Y, Liu C
Biomedicines. 2023; 11(5).
PMID: 37239085
PMC: 10216327.
DOI: 10.3390/biomedicines11051414.
ERK Inhibition Promotes Engraftment of Allografts by Reprogramming T-Cell Metabolism.
Tan X, Qi C, Zhao X, Sun L, Wu M, Sun W
Adv Sci (Weinh). 2023; 10(16):e2206768.
PMID: 37013935
PMC: 10238213.
DOI: 10.1002/advs.202206768.
Congenic hematopoietic stem cell transplantation promotes survival of heart allografts in murine models of acute and chronic rejection.
Sadozai H, Rojas-Luengas V, Farrokhi K, Moshkelgosha S, Guo Q, He W
Clin Exp Immunol. 2023; 213(1):138-154.
PMID: 37004176
PMC: 10324556.
DOI: 10.1093/cei/uxad038.
Failure of Costimulatory Blockade-induced Regulatory T Cells to Sustain Long-term Survival of High Ischemic Allografts.
Kohei N, Tanaka T, Miyairi S, Tsuda H, Abe T, Su C
Transplantation. 2023; 107(9):1935-1944.
PMID: 36978228
PMC: 10514235.
DOI: 10.1097/TP.0000000000004570.
Transport-Associated Vibrational Stress Triggers Drug-Reversible Apoptosis and Cardiac Allograft Failure in Mice.
Lee Y, Gavzy S, Jang J, Kamberi S, Zhang T, Sands L
IEEE J Transl Eng Health Med. 2023; 11:145-150.
PMID: 36816099
PMC: 9904449.
DOI: 10.1109/JTEHM.2023.3239790.
Donor Macrophages Modulate Rejection After Heart Transplantation.
Kopecky B, Dun H, Amrute J, Lin C, Bredemeyer A, Terada Y
Circulation. 2022; 146(8):623-638.
PMID: 35880523
PMC: 9398940.
DOI: 10.1161/CIRCULATIONAHA.121.057400.
Lymph node fibroblastic reticular cells preserve a tolerogenic niche in allograft transplantation through laminin α4.
Li L, Shirkey M, Zhang T, Piao W, Li X, Zhao J
J Clin Invest. 2022; 132(13).
PMID: 35775481
PMC: 9246384.
DOI: 10.1172/JCI156994.
Heat shock protein 90 is a new potential target of anti-rejection therapy in allotransplantation.
Maehana T, Tanaka T, Hashimoto K, Kobayashi K, Kitamura H, Masumori N
Cell Stress Chaperones. 2022; 27(4):337-351.
PMID: 35397061
PMC: 9346020.
DOI: 10.1007/s12192-022-01272-2.
Oridonin Prolongs the Survival of Mouse Cardiac Allografts by Attenuating the NF-κB/NLRP3 Pathway.
Du X, Que W, Hu X, Yu X, Guo W, Zhang S
Front Immunol. 2021; 12:719574.
PMID: 34566976
PMC: 8462485.
DOI: 10.3389/fimmu.2021.719574.
The role of IL-6 in hyperlipidemia-induced accelerated rejection.
Williams L, Bagley J, Iacomini J
Am J Transplant. 2021; 22(2):427-437.
PMID: 34551194
PMC: 8813896.
DOI: 10.1111/ajt.16852.
Increasing the efficacy and safety of a human complement inhibitor for treating post-transplant cardiac ischemia reperfusion injury by targeting to a graft-specific neoepitope.
Zheng C, Sleiman M, Yang X, He S, Atkinson C, Tomlinson S
J Heart Lung Transplant. 2021; 40(10):1112-1121.
PMID: 34334299
PMC: 10587835.
DOI: 10.1016/j.healun.2021.07.004.
